NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study

NCT06269640 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Stopped Clinical trials terminated early due to trial feasibility

Conditions

Hypertrophic Cardiomyopathy
Left Ventricular Septal Hypertrophy
Mitral Valve Disease
Aortic Valve Stenosis

Interventions

DEVICE: Septal Scoring Along Midline Endocardium

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)